|1.||De Rosa, Salvatore: 2 articles (04/2015 - 01/2008)|
|2.||Namba, Takushi: 1 article (04/2015)|
|3.||Tommonaro, Giuseppina: 1 article (04/2015)|
|4.||Iodice, Carmine: 1 article (04/2015)|
|5.||Kodama, Rika: 1 article (04/2015)|
|6.||Tafuto, Antonietta: 1 article (04/2015)|
|7.||Pejin, Boris: 1 article (04/2015)|
|8.||Payá, Miguel: 1 article (01/2008)|
|9.||Amigó, Maria: 1 article (01/2008)|
|10.||Terencio, Maria Carmen: 1 article (01/2008)|
|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
01/30/2008 - "In the present study we evaluated the pharmacological effect of avarol on some inflammatory parameters related to the pathogenesis of psoriasis. "
04/20/2005 - "We concluded that avarol produced by mariculture or ex situ culture could become a viable alternative to currently used pharmaceuticals for the treatment of psoriasis. "
01/30/2008 - "In the psoriasis-like model of 12-O-tetradecanoylphorbol-acetate-induced mouse epidermal hyperplasia, topical administration of avarol (0.6-1.2 micromol/site) reduced edema, myeloperoxidase activity, IL-1beta, IL-2 and eicosanoid levels in skin. "
05/01/1988 - "Our studies demonstrate that avarol displays, besides its potential anti-tumor and anti-HIV activity, a potential immunomodulating effect."
10/01/1985 - "dose of avarone increased life span over controls by 146% when treatment was begun 1 day after tumor implantation and by 87% when treatment was delayed until day 8. Avarol, although active, was less effective. "
05/01/1987 - "The stimulatory influence of avarol on humoral immune responses is not accompanied by a change of the antibody-mediated hypersensitivity reaction, as measured by the Arthus reaction. "
05/01/1987 - "No significant influence of avarol on the cellular immune system in vivo (rats or mice) was found, as taken from studies on delayed-type hypersensitivity reactions to sheep red blood cells and to oxazolone. "
01/01/1985 - "Using the L5178y mouse lymphoma cell system in vitro (roller tube assays) avarol reduced cell growth to 50% at a concentration of 0.9 microM. "
04/01/1988 - "In vivo experiments with L5178y mouse lymphoma cells in the ascites of mice revealed that the cytostatic potencies of avarol and avarone cannot be augmented by lowering the pH value. "
04/01/1988 - "Action of the antileukemic and anti-HTLV-III (anti-HIV) agent avarol on the levels of superoxide dismutases and glutathione peroxidase activities in L5178y mouse lymphoma cells."
|4.||DNA (Deoxyribonucleic Acid)
|5.||Antimutagenic Agents (Antimutagens)
|7.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|8.||Proteins (Proteins, Gene)